Print Friendly, PDF & Email

NCT/Study#

NCT03033914 /

MSK16-1536

Phase I/II Of Nivolumab And A(B)VD In The Front-Line Setting For High Risk Hodgkin Lymphoma

DISEASE GROUP:

Lymphoma

current phase:

Phase I/II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587